106 related articles for article (PubMed ID: 3872054)
1. Hemodynamic assessment of intravenous bepridil administration in ischemic heart disease.
Tamari I; Borer JS; Moses JW; Goldberg HL; Fisher J; Wallis JB; Halle A
Am J Cardiol; 1985 Mar; 55(7):25C-29C. PubMed ID: 3872054
[TBL] [Abstract][Full Text] [Related]
2. Hemodynamic effects of intravenous bepridil in patients with normal left ventricular function.
Alpert JS; Benotti JR; Brady PM; McCue JE; Weiner BH; Ockene IS
Am J Cardiol; 1985 Mar; 55(7):20C-24C. PubMed ID: 3872053
[TBL] [Abstract][Full Text] [Related]
3. Effects on hemodynamics and left ventricular ejection fraction of intravenous bepridil for impaired left ventricular function secondary to coronary artery disease.
Josephson MA; Mody T; Coyle K; Singh BN
Am J Cardiol; 1987 Jul; 60(1):44-9. PubMed ID: 3496779
[TBL] [Abstract][Full Text] [Related]
4. Acute hemodynamic and antiischemic properties of intravenous bepridil in coronary artery disease.
Remme WJ; Kruyssen DA; Van Hoogenhuyze DC; Hofman B; Krauss XH; Storm CJ
Am J Cardiol; 1989 Mar; 63(11):670-5. PubMed ID: 2784281
[TBL] [Abstract][Full Text] [Related]
5. Dose related coronary and systemic haemodynamic effects of intravenous bepridil in patients with coronary artery disease.
Remme WJ; van Hoogenhuyze DC; Krauss XH; Hofman A; Storm CJ; Kruyssen HA
Eur Heart J; 1987 Feb; 8(2):130-40. PubMed ID: 3494607
[TBL] [Abstract][Full Text] [Related]
6. Hemodynamic effects of intravenous diltiazem with impaired left ventricular function.
Materne P; Legrand V; Vandormael M; Collignon P; Kulbertus HE
Am J Cardiol; 1984 Oct; 54(7):733-7. PubMed ID: 6486022
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular actions after intravenous and intracoronary administration of the slow channel blocker bepridil.
Verdouw PD; Scheffer MG
Arzneimittelforschung; 1984; 34(1):21-5. PubMed ID: 6608356
[TBL] [Abstract][Full Text] [Related]
8. Hemodynamic effects of a new calcium antagonist, SR 33557, in patients with coronary artery disease and normal left ventricular function.
Saal JP; Lellouche D; Habbal R; Sissmann J; Castaigne A; Dubois-Randé JL
J Cardiovasc Pharmacol; 1994 Jan; 23(1):87-91. PubMed ID: 7511741
[TBL] [Abstract][Full Text] [Related]
9. [Hemodynamic effects of a new calcium antagonist, bepridil, in patients with coronary artery disease].
Haerer VW; Stauch M
Arzneimittelforschung; 1987 Jul; 37(7):829-31. PubMed ID: 3499908
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular profile of 5 novel nitrate-esters: a comparative study with nitroglycerin in pigs with and without left ventricular dysfunction.
van Woerkens LJ; van der Giessen WJ; Verdouw PD
Br J Pharmacol; 1991 Sep; 104(1):7-14. PubMed ID: 1786521
[TBL] [Abstract][Full Text] [Related]
11. Hemodynamic actions of bepridil during treatment of stable angina pectoris.
Narahara KA; Shapiro W; Weliky I; Park J
Am J Cardiol; 1985 Mar; 55(7):55C-58C. PubMed ID: 3883742
[TBL] [Abstract][Full Text] [Related]
12. Electrophysiologic, hemodynamic and metabolic effects of intravenous bepridil hydrochloride.
Upward JW; Daly K; Campbell S; Bergman G; Jewitt DE
Am J Cardiol; 1985 Jun; 55(13 Pt 1):1589-95. PubMed ID: 3873868
[TBL] [Abstract][Full Text] [Related]
13. Hemodynamic effects of bepridil in patients with coronary artery disease.
Narahara KA
Am J Cardiol; 1992 Apr; 69(11):17D-24D. PubMed ID: 1553887
[TBL] [Abstract][Full Text] [Related]
14. [Bepridil: hemodynamic and coronary effects on normal and/or ischemic myocardium in dogs (author's transl)].
Berdeaux A; Kantelip JP; Eschalier A; Giudicelli JF; Duchene-Marullaz P
J Pharmacol; 1980; 11(4):391-409. PubMed ID: 6970858
[TBL] [Abstract][Full Text] [Related]
15. Comparative effects of bepridil, diltiazem, nifedipine and verapamil on haemodynamic parameters and myocardial oxygen consumption in anaesthetized dogs.
Beaughard M; Michelin MT; Tisne-Versailles J; Lamar JC
Arch Int Pharmacodyn Ther; 1986 Dec; 284(2):276-96. PubMed ID: 3493742
[TBL] [Abstract][Full Text] [Related]
16. Direct cardiac and peripheral vascular effects of intracoronary and intravenous nifedipine.
Terris S; Bourdillon PD; Cheng DT; Pitt B
Am J Cardiol; 1986 Jul; 58(1):25-30. PubMed ID: 3728327
[TBL] [Abstract][Full Text] [Related]
17. Coronary and systemic hemodynamic effects of nicardipine.
Lambert CR; Hill JA; Nichols WW; Feldman RL; Pepine CJ
Am J Cardiol; 1985 Mar; 55(6):652-6. PubMed ID: 3976506
[TBL] [Abstract][Full Text] [Related]
18. [Calcium antagonists: effect on peripheral and coronary hemodynamics].
Simon R
Z Kardiol; 1984; 73 Suppl 2():79-88. PubMed ID: 6528705
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular effects of vasopressors in isoflurane-anesthetized dogs before and after hemorrhage.
Curtis MB; Bednarski RM; Majors L
Am J Vet Res; 1989 Nov; 50(11):1866-71. PubMed ID: 2619117
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular effects of vasopressors in halothane-anesthetized dogs before and after hemorrhage.
Curtis MB; Bednarski RM; Majors L
Am J Vet Res; 1989 Nov; 50(11):1859-65. PubMed ID: 2619116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
